GlassScriptPhysician profile
Luis Carlos Murillo
NPI 1093938573
$6,653.80
in general payments reported to CMS, 2019-2025
40 companies · $1,076 in 2025
The $1,076 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,648 · 2020: $125 · 2021: $727 · 2022: $1,121 · 2023: $1,115 · 2024: $841 · 2025: $1,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,966 · Education: $66.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,966.04 |
| Education | $66.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $1,365.07 | 2019-2025 | Smartvest |
| Astrazeneca Pharmaceuticals LP | $755.39 | 2019-2025 | Tezspire, Fasenra, Symbicort |
| Glaxosmithkline, LLC. | $457.38 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Insmed, INC. | $371.90 | 2019-2025 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $366.70 | 2019-2025 | Ofev |
| Actelion Pharmaceuticals US, INC. | $326.53 | 2019-2024 | Opsumit |
| Chiesi USA, INC. | $261.91 | 2019-2023 | Bronchitol |
| Mylan Specialty L.P. | $240.73 | 2019-2024 | Yupelri |
| Allergan, INC. | $240.53 | 2019 | |
| Jazz Pharmaceuticals INC. | $220.67 | 2019-2024 | |
| Digestive Care, INC. | $192.65 | 2025 | Pertzye |
| Regeneron Healthcare Solutions, INC. | $191.00 | 2019-2025 | Dupixent |
| Abbvie INC. | $150.77 | 2021-2025 | |
| Gilead Sciences, INC. | $142.64 | 2019-2021 | |
| Abiomed | $131.27 | 2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcresta Therapeutics, INC. | $121.24 | 2023-2024 | Relizorb |
| Philips North America LLC | $118.90 | 2019-2025 | Vest Therapy Und |
| Genentech USA, INC. | $115.01 | 2019-2025 | Xolair |
| Nestle Healthcare Nutrition INC. | $105.83 | 2021-2023 | |
| Amgen INC. | $79.02 | 2022-2024 | Tezspire |
| Aimmune Therapeutics, INC. | $77.55 | 2024-2025 | Zenpep |
| Genzyme Corporation | $71.15 | 2019-2023 | |
| Inspire Medical Systems, INC. | $69.25 | 2023-2024 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $63.19 | 2021-2022 | |
| Viatris Specialty LLC | $41.14 | 2025 | Tobi Podhaler, Yupelri |
| United Therapeutics Corporation | $38.50 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $38.17 | 2019-2023 | Dificid, Zerbaxa, Recarbrio |
| Baxter Healthcare | $35.52 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Sunovion Pharmaceuticals INC. | $33.59 | 2019 | |
| Verona Pharma, INC. | $32.62 | 2025 | Ohtuvayre |
| Avadel Cns Pharmaceuticals, LLC | $30.70 | 2025 | Lumryz |
| Vapotherm INC | $27.47 | 2022 | |
| Grifols USA, LLC | $24.15 | 2019 | |
| Lilly USA, LLC | $19.04 | 2025 | Zepbound |
| 3b Medical, INC. | $18.97 | 2024 | Luna |
| Paratek Pharmaceuticals, INC. | $17.46 | 2023 | Nuzyra |
| Resmed Corp | $16.69 | 2025 | |
| Alexion Pharmaceuticals, INC. | $16.49 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.41 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Murillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.